APR September/October 2020 - 102
»
MICROBIOLOGY
»
Is a Difference in LAL Reagent
Results Possible?
Yes. The LAL reagents are derived from horseshoe crabs and are
therefore of biological origin. It has been described that the lysate
is a relatively crude mixture and is not a single purified enzyme. This
means that the enzyme activity cannot be determined exactly for each
lot of lysate manufactured. Furthermore, the manufacturing process
includes the addition of buffers and detergents which contribute a
further source of variability.1 A reduced variability can be achieved by
using recombinant Factor C reagents.
Can a Variation in the Standard Curve
Effect the Test Result?
Yes. To quantify bacterial endotoxin, a standard curve is prepared in
order to determine the endotoxin activity of a sample. Therefore, the
quality of the standard curve is the basis of quantification. Using a
linear standard curve, a change of only 1% in y-intercept can result in a
change of up to 35% in measured endotoxin activity.1
In Figure 1, Y-intercept (Y-Achsenabschnitt) as a function of number of
analysis (Analysennummer) from trending analysis is shown. All data
points (full diamonds) fulfill the standard acceptance criteria. However,
the typical observed variations may lead to increased/decreased test
results depending on the y-intercept as small variations can lead to
relative high variations in measured EU/mL.
are ultimately biological assays, the lysates are intrinsically variable.2
Moreover, recent challenges like LER and the implementation of
recombinant tests brought up again discussions about Naturally
Occurring Endotoxins (NOE). Advocates of NOE in the field of LER are
refusing NOE when it comes to the comparison of test methods. It has
been stated that NOE more closely mimics a real life contamination
event,3 but on the other hand it has been communicated that NOEs
grown in laboratory are not representative of what occurs in nature.
This contradictoriness clearly reflects the incongruous application of
undefined endotoxin spikes during testing.
Can a Sample Composition Alter the
Detectability of Endotoxin?
Yes. There have been a lot of publications about Low Endotoxin
Recovery (LER) and endotoxin masking which can lead to
underestimation of endotoxin contents.2,4-6 Due to the presence
of certain excipients or active pharmaceutical ingredients or
combinations thereof, endotoxin can be masked. An example for the
detectability of endotoxin in a typical LER matrix is given in Table 1.
Thereby the detectability decreases although the endotoxin is not
degraded and potentially hazardous.
In order to reveal these effects so called LER studies are mandatory.
Table 1. Detection of endotoxin over time in a typical LER matrix
Low Endotoxin Recovery Study
[EU/mL]
M1 Time Point 0 days
64.0
M2 Time Point 1 days
27.8
M3 Time Point 2 days
17.6
M4 Time Point 3 days
7.3
M5 Time Point 7 days
4.8
The data is sourced from Low Endotoxin Recovery - Masking of Naturally Occurring Endotoxin6
Therefore, undiluted samples are spiked with endotoxin and held for a
certain period of time. More guidance for LER including strategies for
demasking is found in the Technical Report No. 82 from PDA.
Figure 1. Y-intercept of standard curves from trending analysis
Is Reference Standard Endotoxin Still
Representative for BET?
Yes. Reference Standard Endotoxin (RSE) is the benchmark and allows
comparability of test methods. Due to the heterogeneity of endotoxin,
standardization of bacterial endotoxin tests was very challenging
in the early time of BET. Only the introduction of RSE was the key
factor to control the quality of BET, since Limulus-based approaches
102 |
APR_SeptOct2020.indd 102
Do (13)-ß-D-Glucans Affect the
Endotoxin Test Result?
Yes. The LAL test includes per se the Factor G reaction pathway which
is described to react with (13)-ß-D-glucans.7 This reaction pathway
has been identified years ago. Interestingly this pathway is unequally
pronounced in different LAL tests. There are also agents available to
repress Factor G reaction pathway. Unfortunately, it is neither proven
that a) all glucans nor b) that their full activity is blocked. Obviously,
glucans are very heterogeneous and present in various aggregation
states and can be derived from a variety of sources. Once present in a
sample the absolute differentiation between LPS and glucans with LAL
is virtually impossible.
| September/October 2020
10/2/20 11:46 AM
APR September/October 2020
Table of Contents for the Digital Edition of APR September/October 2020
Table of Contents
APR September/October 2020 - Cover1
APR September/October 2020 - Cover2
APR September/October 2020 - 1
APR September/October 2020 - 2
APR September/October 2020 - Table of Contents
APR September/October 2020 - 4
APR September/October 2020 - 5
APR September/October 2020 - 6
APR September/October 2020 - 7
APR September/October 2020 - 8
APR September/October 2020 - 9
APR September/October 2020 - 10
APR September/October 2020 - 11
APR September/October 2020 - 12
APR September/October 2020 - 13
APR September/October 2020 - 14
APR September/October 2020 - 15
APR September/October 2020 - 16
APR September/October 2020 - 17
APR September/October 2020 - 18
APR September/October 2020 - 19
APR September/October 2020 - 20
APR September/October 2020 - 21
APR September/October 2020 - 22
APR September/October 2020 - 23
APR September/October 2020 - 24
APR September/October 2020 - 25
APR September/October 2020 - 26
APR September/October 2020 - 27
APR September/October 2020 - 28
APR September/October 2020 - 29
APR September/October 2020 - 30
APR September/October 2020 - 31
APR September/October 2020 - 32
APR September/October 2020 - 33
APR September/October 2020 - 34
APR September/October 2020 - 35
APR September/October 2020 - 36
APR September/October 2020 - 37
APR September/October 2020 - 38
APR September/October 2020 - 39
APR September/October 2020 - 40
APR September/October 2020 - 41
APR September/October 2020 - 42
APR September/October 2020 - 43
APR September/October 2020 - 44
APR September/October 2020 - 45
APR September/October 2020 - 46
APR September/October 2020 - 47
APR September/October 2020 - 48
APR September/October 2020 - 49
APR September/October 2020 - 50
APR September/October 2020 - 51
APR September/October 2020 - 52
APR September/October 2020 - 53
APR September/October 2020 - 54
APR September/October 2020 - 55
APR September/October 2020 - 56
APR September/October 2020 - 57
APR September/October 2020 - 58
APR September/October 2020 - 59
APR September/October 2020 - 60
APR September/October 2020 - 61
APR September/October 2020 - 62
APR September/October 2020 - 63
APR September/October 2020 - 64
APR September/October 2020 - 65
APR September/October 2020 - 66
APR September/October 2020 - 67
APR September/October 2020 - 68
APR September/October 2020 - 69
APR September/October 2020 - 70
APR September/October 2020 - 71
APR September/October 2020 - 72
APR September/October 2020 - 73
APR September/October 2020 - 74
APR September/October 2020 - 75
APR September/October 2020 - 76
APR September/October 2020 - 77
APR September/October 2020 - 78
APR September/October 2020 - 79
APR September/October 2020 - 80
APR September/October 2020 - 81
APR September/October 2020 - 82
APR September/October 2020 - 83
APR September/October 2020 - 84
APR September/October 2020 - 85
APR September/October 2020 - 86
APR September/October 2020 - 87
APR September/October 2020 - 88
APR September/October 2020 - 89
APR September/October 2020 - 90
APR September/October 2020 - 91
APR September/October 2020 - 92
APR September/October 2020 - 93
APR September/October 2020 - 94
APR September/October 2020 - 95
APR September/October 2020 - 96
APR September/October 2020 - 97
APR September/October 2020 - 98
APR September/October 2020 - 99
APR September/October 2020 - 100
APR September/October 2020 - 101
APR September/October 2020 - 102
APR September/October 2020 - 103
APR September/October 2020 - 104
APR September/October 2020 - 105
APR September/October 2020 - 106
APR September/October 2020 - 107
APR September/October 2020 - 108
APR September/October 2020 - 109
APR September/October 2020 - 110
APR September/October 2020 - 111
APR September/October 2020 - 112
APR September/October 2020 - 113
APR September/October 2020 - 114
APR September/October 2020 - 115
APR September/October 2020 - 116
APR September/October 2020 - 117
APR September/October 2020 - 118
APR September/October 2020 - 119
APR September/October 2020 - 120
APR September/October 2020 - 121
APR September/October 2020 - 122
APR September/October 2020 - 123
APR September/October 2020 - 124
APR September/October 2020 - 125
APR September/October 2020 - 126
APR September/October 2020 - 127
APR September/October 2020 - 128
APR September/October 2020 - 129
APR September/October 2020 - 130
APR September/October 2020 - 131
APR September/October 2020 - 132
APR September/October 2020 - 133
APR September/October 2020 - 134
APR September/October 2020 - 135
APR September/October 2020 - 136
APR September/October 2020 - 137
APR September/October 2020 - 138
APR September/October 2020 - 139
APR September/October 2020 - 140
APR September/October 2020 - 141
APR September/October 2020 - 142
APR September/October 2020 - 143
APR September/October 2020 - 144
APR September/October 2020 - 145
APR September/October 2020 - 146
APR September/October 2020 - 147
APR September/October 2020 - 148
APR September/October 2020 - 149
APR September/October 2020 - 150
APR September/October 2020 - 151
APR September/October 2020 - 152
APR September/October 2020 - 153
APR September/October 2020 - 154
APR September/October 2020 - 155
APR September/October 2020 - 156
APR September/October 2020 - 157
APR September/October 2020 - 158
APR September/October 2020 - 159
APR September/October 2020 - 160
APR September/October 2020 - 161
APR September/October 2020 - 162
APR September/October 2020 - 163
APR September/October 2020 - 164
APR September/October 2020 - 165
APR September/October 2020 - 166
APR September/October 2020 - 167
APR September/October 2020 - 168
APR September/October 2020 - Cover3
APR September/October 2020 - Cover4
https://www.nxtbook.com/comparenetworks/AmericanPharmaceuticalRevew/apr-innovations-at-interphex-guide-april-2022
https://www.nxtbook.com/comparenetworks/AmericanPharmaceuticalRevew/APRNovDec2020
https://www.nxtbook.com/comparenetworks/AmericanPharmaceuticalRevew/APRSeptOct2020
https://www.nxtbookmedia.com